MedAvail Holdings, Inc.: Nasdaq/NYSE listing notice — MedAvail receives Nasdaq deficiency notice for bid price below $1.00

MedAvail Holdings, Inc.

Nasdaq letter dated Oct 31, 2022; common stock bid price below $1.00 for 30 consecutive business days.
180-day compliance period ends May 1, 2023; must close at $1.00 for 10 consecutive days to regain compliance.
If not compliant by May 1, may seek additional 180 days by meeting other listing standards and effecting a reverse stock split.
Company may appeal any delisting determination but no assurance of success.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

MedAvail Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

October 31, 2021, MedAvail Holdings, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The letter also indicated that the Company will be provided with a compliance period of 180 calend

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001402479-22-000083

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.